Martin Teraa

3.8k total citations
71 papers, 1.9k citations indexed

About

Martin Teraa is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Martin Teraa has authored 71 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Surgery, 28 papers in Pulmonary and Respiratory Medicine and 19 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Martin Teraa's work include Peripheral Artery Disease Management (40 papers), Diabetic Foot Ulcer Assessment and Management (16 papers) and Cerebrovascular and Carotid Artery Diseases (13 papers). Martin Teraa is often cited by papers focused on Peripheral Artery Disease Management (40 papers), Diabetic Foot Ulcer Assessment and Management (16 papers) and Cerebrovascular and Carotid Artery Diseases (13 papers). Martin Teraa collaborates with scholars based in Netherlands, United States and United Kingdom. Martin Teraa's co-authors include Marianne C. Verhaar, Frans L. Moll, Gert J. de Borst, Michael S. Conte, Ralf W. Sprengers, Hendrik Gremmels, Gianmarco de Donato, Florian Dick, Nicolas Diehm and F. Becker and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Martin Teraa

61 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Teraa Netherlands 23 1.3k 517 491 471 253 71 1.9k
Takashi Ohta Japan 23 937 0.7× 264 0.5× 407 0.8× 827 1.8× 425 1.7× 151 2.1k
Holger Lawall Germany 18 702 0.5× 283 0.5× 179 0.4× 329 0.7× 97 0.4× 76 1.1k
Sergio Losa Italy 13 702 0.5× 462 0.9× 371 0.8× 319 0.7× 81 0.3× 23 1.3k
Lee J. Goldstein United States 16 728 0.6× 365 0.7× 440 0.9× 1.2k 2.6× 282 1.1× 36 2.4k
Roberto Ferraresi Italy 19 920 0.7× 495 1.0× 94 0.2× 429 0.9× 61 0.2× 58 1.3k
Rachael O. Forsythe United Kingdom 22 673 0.5× 728 1.4× 151 0.3× 489 1.0× 42 0.2× 58 1.8k
Tzu‐Hsien Tsai Taiwan 24 542 0.4× 106 0.2× 454 0.9× 247 0.5× 337 1.3× 66 1.7k
Abbey Schepers Netherlands 21 693 0.5× 269 0.5× 341 0.7× 328 0.7× 52 0.2× 77 1.5k
Takafumi Ueno Japan 24 1.3k 1.0× 106 0.2× 1.1k 2.3× 603 1.3× 496 2.0× 92 3.1k
Paul Baskerville United Kingdom 17 912 0.7× 142 0.3× 439 0.9× 348 0.7× 56 0.2× 29 1.8k

Countries citing papers authored by Martin Teraa

Since Specialization
Citations

This map shows the geographic impact of Martin Teraa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Teraa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Teraa more than expected).

Fields of papers citing papers by Martin Teraa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Teraa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Teraa. The network helps show where Martin Teraa may publish in the future.

Co-authorship network of co-authors of Martin Teraa

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Teraa. A scholar is included among the top collaborators of Martin Teraa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Teraa. Martin Teraa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Schouw, Yvonne T. van der, Johanna M. Geleijnse, Jannick A N Dorresteijn, et al.. (2025). The relationship between the EAT-Lancet dietary pattern and risk of cardiovascular events in patients with established cardiovascular disease. European Journal of Nutrition. 64(8). 324–324.
4.
Lareyre, Fabien & Martin Teraa. (2024). Behind a Random Forest, a Brighter Future for Patients with Abdominal Aortic Aneurysm?. European Journal of Vascular and Endovascular Surgery. 69(4). 599–600.
5.
Teraa, Martin, Raechel J. Toorop, Dan Wu, et al.. (2024). Off‐the‐Shelf Synthetic Biodegradable Grafts Transform In Situ into a Living Arteriovenous Fistula in a Large Animal Model. Advanced Healthcare Materials. 13(17). e2303888–e2303888. 3 indexed citations
6.
Hageman, Steven H J, Martin Teraa, Manon G. van der Meer, et al.. (2024). Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular disease. Heart. 110(7). heartjnl–2023. 2 indexed citations
7.
Boer, Annemarijn R de, et al.. (2024). Sex Differences in Mortality Risk after the First Hospitalisation with Lower Extremity Peripheral Arterial Disease. European Journal of Vascular and Endovascular Surgery. 68(3). 378–384.
8.
Krebber, Merle M., Joost O. Fledderus, Martin Teraa, et al.. (2023). The effect of chronic kidney disease on tissue formation of in situ tissue-engineered vascular grafts. APL Bioengineering. 7(2). 26107–26107. 3 indexed citations
9.
Hazenberg, Constantijn E.V.B., et al.. (2023). Editor's Choice – Radiation Dose Reduction During Contralateral Limb Cannulation Using Fiber Optic RealShape Technology in Endovascular Aneurysm Repair. European Journal of Vascular and Endovascular Surgery. 67(4). 594–600. 2 indexed citations
10.
Burger, P.M., Aruna D. Pradhan, Jannick A N Dorresteijn, et al.. (2023). C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations. The American Journal of Cardiology. 197. 13–23. 31 indexed citations
11.
Gremmels, Hendrik, et al.. (2022). Human Bone Marrow Mononuclear Cells Do Not Improve Limb Perfusion in the Hindlimb Ischemia Model. Stem Cells and Development. 31(7-8). 176–180. 3 indexed citations
12.
Borst, Gert de, Albert Busch, Panagiotis G. Doukas, et al.. (2022). Study Protocol of a Prospective Multicenter Observational Study Evaluating Acute Lower Limb Ischemia. Journal of Surgical Research. 282. 280–284. 1 indexed citations
13.
Mes, Tristan, Anton W. Bosman, Joris W. Peeters, et al.. (2021). The in‐vitro biocompatibility of ureido‐pyrimidinone compounds and polymer degradation products. Journal of Polymer Science. 59(12). 1267–1277. 13 indexed citations
14.
Hanssen, Nordin M.J., Martin Teraa, Jean L.J.M. Scheijen, et al.. (2020). Plasma Methylglyoxal Levels Are Associated With Amputations and Mortality in Severe Limb Ischemia Patients With and Without Diabetes. Diabetes Care. 44(1). 157–163. 16 indexed citations
15.
Gremmels, Hendrik, Martin Teraa, Saskia C.A. de Jager, et al.. (2019). A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia. Scientific Reports. 9(1). 10740–10740. 23 indexed citations
17.
Teraa, Martin, et al.. (2017). Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia. Journal of Vascular Surgery. 67(2). 656–661. 23 indexed citations
18.
Teraa, Martin, et al.. (2015). Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials. European Journal of Vascular and Endovascular Surgery. 50(6). 775–783. 81 indexed citations
19.
Teraa, Martin, et al.. (2013). Stem Cell Trials for Cardiovascular Medicine: Ethical Rationale. Tissue Engineering Part A. 20(19-20). 2567–2574. 19 indexed citations
20.
Teraa, Martin, Taco J. Blokhuis, Lisa Tang, & Luke P. H. Leenen. (2012). Segmental Tibial Fractures: An Infrequent but Demanding Injury. Clinical Orthopaedics and Related Research. 471(9). 2790–2796. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026